2B4 (CD244) signaling via chimeric receptors costimulates tumor-antigen specific proliferation and in vitro expansion of human T cells

Cancer Immunology, Immunotherapy

Volumn 58, Issue 12, 2009, Pages 1991-2001

  Altvater, Bianca ^a   Landmeier, Silke ^a   Pscherer, Sibylle ^a   Temme, Jaane ^a   Juergens, Heribert ^a   Pule, Martin ^a   Rossig, Claudia ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Costimulation; Immunotherapy; NK cell receptors; T cells

Indexed keywords

CD244 PROTEIN, HUMAN; EPITOPE; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN PRESENTATION; ARTICLE; CELL GROWTH; GENETICS; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; NATURAL KILLER CELL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR CELL LINE;

ANTIGEN PRESENTATION; ANTIGENS, CD; CELL GROWTH PROCESSES; CELL LINE, TUMOR; EPITOPES; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 79958097537     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-009-0704-9     Document Type: Article

References (48)

1. Eshhar Z, Waks T, Gross G, Schindler DG (1993) Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T cell receptors. Proc Natl Acad Sci USA 90:720-724 (Pubitemid 23028937)
2. Brentjens RJ, Latouche JB, Santos E, Marti F, Gong MC, Lyddane C, King PD, Larson S, Weiss M, Riviere I, Sadelain M (2003) Eradication of systemic B cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nat Med 9:279-286 (Pubitemid 36362782)
3. Brocker T (2000) Chimeric Fv-zeta or Fv-epsilon receptors are not sufficient to induce activation or cytokine production in peripheral T cells. Blood 96:1999-2001
4. Kershaw MH, Westwood JA, Parker LL, Wang G, Eshhar Z, Mavroukakis SA, White DE, Wunderlich JR, Canevari S, Rogers- Freezer L, Chen CC, Yang JC, Rosenberg SA, Hwu P (2006) A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer. Clin Cancer Res 12:6106-6115 (Pubitemid 44703776)
5. Lamers CHJ, Langeveld SCL, Ruijven CMGV, Debets R, Sleijfer S, Gratama JW (2007) Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo. Cancer Immunol Immunother 56:1875-1883 (Pubitemid 47512609)
6. Mitsuyasu RT, Anton PA, Deeks SG, Scadden DT, Connick E, Downs MT, Bakker A, Roberts MR, June CH, Jalali S, Lin AA, Pennathur-Das R, Hege KM (2000) Prolonged survival and tissue traficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects. Blood 96:785-793 (Pubitemid 30616838)
7. Park JR, DiGiusto DL, Slovak M, Wright C, Naranjo A, Wagner J, Meechoovet HB, Bautista C, Chang WC, Ostberg JR, Jensen MC (2007) Adoptive transfer of chimeric antigen receptor redirected cytolytic T lymphocyte clones in patients with neuroblastoma. Mol Ther 15:825-833 (Pubitemid 46432004)
8. Till BG, Jensen MC, Wang J, Chen EY, Wood BL, Greisman HA, Qian X, James SE, Raubitschek A, Forman SJ, Gopal AK, Pagel JM, Lindgren CG, Greenberg PD, Riddell SR, Press OW (2008) Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells. Blood 112:2261-2271
9. Finney HM, Lawson AD, Bebbington CR, Weir AN (1998) Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product. J Immunol 161:2791-2797 (Pubitemid 28425698)
10. Maher J, Brentjens RJ, Gunset G, Riviere I, Sadelain M (2002) Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta/CD28 receptor. Nat Biotechnol 20:70-75 (Pubitemid 34044918)
11. Imai C, Mihara K, Andreansky M, Nicholson IC, Pui CH, Geiger TL, Campana D (2004) Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. Leukemia 18:676-684 (Pubitemid 38500185)
12. Pule MA, Straathof KC, Dotti G, Heslop HE, Rooney CM, Brenner MK (2005) A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells. Mol Ther 12:933-941 (Pubitemid 41614489)
13. Raulet DH (2004) Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 5:996-1002
14. Chuang SS, Kumaresan PR, Mathew PA (2001) 2B4 (CD244)- mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways. J Immunol 167:6210-6216 (Pubitemid 33081549)
15. Garniwagner BA, Purohit A, Mathew PA, Bennett M, Kumar V (1993) A novel function-associated molecule related to non-Mhc-restricted cytotoxicity mediated by activated natural-killer-cells and T cells. J Immunol 151:60-70 (Pubitemid 23206971)
16. Lee KM, Bhawan S, Majima T, Wei BR, Nishimura MI, Yagita H, Kumar V (2003) Cutting edge: the NK cell receptor 2B4 augments antigen-speciflic T cell cytotoxicity through CD48 ligation on neighboring T cells. J Immunol 170:4881-4885 (Pubitemid 36554715)
17. Mathew PA, Garniwagner BA, Land K, Takashima A, Stoneman E, Bennett M, Kumar V (1993) Cloning and characterization of the 2B4 gene encoding a molecule associated with non-Mhc-restricted killing mediated by activated natural-killer-cells and T Cells. J Immunol 151:5328-5337 (Pubitemid 23332342)
18. Nakajima H, Cella M, Langen H, Friedlein A, Colonna M (1999) Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur J Immunol 29:1676-1683 (Pubitemid 29224473)
19. Valiante NM, Trinchieri G (1993) Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J Exp Med 178:1397-1406 (Pubitemid 23277371)
20. Sivori S, Falco M, Marcenaro E, Parolini S, Biassoni R, Bottino C, Moretta L, Moretta A (2002) Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc Natl Acad Sci USA 99:4526-4531 (Pubitemid 34286018)
21. Boles KS, Nakajima H, Colonna M, Chuang SS, Stepp SE, Bennett M, Kumar V, Mathew PA (1999) Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4. Tissue Antigens 54:27-34 (Pubitemid 29326927)
22. Speiser DE, Colonna M, Ayyoub M, Cella M, Pittet MJ, Batard P, Valmori D, Guillaume P, Lienard D, Cerottini JC, Romero P (2001) The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells. J Immunol 167:6165-6170 (Pubitemid 33081543)
23. Yokoyama S, Staunton D, Fisher R, Amiot M, Fortin JJ, Thorley- Lawson DA (1991) Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. J Immunol 146:2192-2200
24. Peritt D, Sesok-Pizzini DA, Schretzenmair R, Macgregor RR, Valiante NM, Tu X, Trinchieri G, Kamoun M (1999) C1.7 antigen expression on CD8(+) T cells is activation dependent: Increased proportion of C1.7(+)CD8(+) T cells in HIV-1-infected patients with progressing disease. J Immunol 162:7563-7568 (Pubitemid 29277738)
25. Dupre L, Andolfi G, Tangye SG, Clementi R, Locatelli F, Arico M, Aiuti A, Roncarolo MG (2005) SAP controls the cytolytic activity of CD8(+) T cells against EBV-infected cells. Blood 105:4383-4389 (Pubitemid 40720785)
26. Rossig C, Bollard CM, Nuchtern JG, Merchant DA, Brenner MK (2001) Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T cell receptor genes. Int J Cancer 94:228-236 (Pubitemid 32911418)
27. Rossig C, Pscherer S, Landmeier S, Altvater B, Jurgens H, Vormoor J (2005) Adoptive cellular immunotherapy with CD19- specific T cells. Klin Padiatr 217:351-356 (Pubitemid 41746118)
28. Riviere I, Brose K, Mulligan RC (1995) Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA 92:6733-6737
29. Kinsella TM, Nolan GP (1996) Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther 7:1405-1413 (Pubitemid 26293560)
30. Hanenberg H, Xiao XL, Dilloo D, Hashino K, Kato I, Williams DA (1996) Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 2:876-882 (Pubitemid 26296757)
31. Rossig C, Bar A, Pscherer S, Altvater B, Pule M, Rooney CM, Brenner MK, Jurgens H, Vormoor J (2006) Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T cell responses via chimeric T cell receptors. J Immunother 29:21-31
32. Altvater B, Pscherer S, Landmeier S, Niggemeier V, Juergens H, Vormoor J, Rossig C (2006) CD28 co-stimulation via tumour-specific chimaeric receptors induces an incomplete activation response in Epstein-Barr virus-specific effector memory T cells. Clin Exp Immunol 144:447-457 (Pubitemid 43799928)
33. Waller ECP, McKinney N, Hicks R, Carmichael AJ, Sissons JGP, Wills MR (2007) Differential costimulation through CD137 (4-1BB) restores proliferation of human virus-specific "effector memory" (CD28(¡) CD45RA(HI)) CD8(+) T cells. Blood 110:4360-4366 (Pubitemid 351377801)
34. Assarsson E, Kambayashi T, Persson CM, Chambers BJ, Ljunggren HG (2005) 2B4/CD48-mediated regulation of lymphocyte activation and function. J Immunol 175:2045-2049 (Pubitemid 41113807)
35. Kambayashi T, Assarsson E, Chambers BJ, Ljunggren HG (2001) Regulation of CD8(+) T cell proliferation by 2B4/CD48 interactions. J Immunol 167:6706-6710 (Pubitemid 33144158)
36. Lee KM, McNerney ME, Stepp SE, Mathew PA, Schatzle JD, Bennett M, Kumar V (2004) 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J Exp Med 199:1245-1254 (Pubitemid 38620261)
37. Eissmann P, Beauchamp L, Wooters J, Tilton JC, Long EO, Watzl C (2005) Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 105:4722-4729 (Pubitemid 40807295)
38. Schatzle JD, Sheu S, Stepp SE, Mathew PA, Bennett M, Kumar V (1999) Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4. Proc Natl Acad Sci USA 96:3870-3875 (Pubitemid 29169003)
39. Chlewicki LK, Velikovsky CA, Balakrishnan V, Mariuzza RA, Kumar V (2008) Molecular basis of the dual functions of 2B4 (CD244). J Immunol 180:8159-8167
40. Assarsson E, Kambayashi T, Schatzle JD, Cramer SO, von Bonin A, Jensen PE, Ljunggren HG, Chambers BJ (2004) NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions. J Immunol 173:174-180 (Pubitemid 38797339)
41. Tangye SG, Lazetic S, Woollatt E, Sutherland GR, Lanier LL, Phillips JH (1999) Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol 162:6981-6985 (Pubitemid 29277663)
42. Nakajima H, Cella M, Bouchon A, Grierson HL, Lewis J, Duckett CS, Cohen JI, Colonna M (2000) Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur J Immunol 30:3309-3318
43. Sharpe AH, Freeman GJ (2002) The B7-CD28 superfamily. Nat Rev Immunol 2:116-126 (Pubitemid 37323235)
44. Chen AI, Mcadam AJ, Buhlmann JE, Scott S, Lupher ML, Greenfield EA, Baum PR, Fanslow WC, Calderhead DM, Freeman GJ, Sharpe AH (1999) Ox40-ligand has a critical costimulatory role in dendritic cell: T cell interactions. Immunity 11:689-698 (Pubitemid 30030708)
45. Rey J, Giustiniani J, Mallet F, Schiavon V, Boumsell L, Bensussan A, Olive D, Costello R (2006) The co-expression of 2B4 (CD244) and CD160 delineates a subpopulation of human CD8(+) T cells with a potent CD160-mediated cytolytic effector function. Eur J Immunol 36:2359-2366 (Pubitemid 44420592)
46. Parolini S, Bottino C, Falco M, Augugliaro R, Giliani S, Franceschini R, Ochs HD, Wolf H, Bonnefoy JY, Biassoni R, Moretta L, Notarangelo LD, Moretta A (2000) X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J Exp Med 192:337-346 (Pubitemid 30629159)
47. Eshhar Z, Waks T, Bendavid A, Schindler DG (2001) Functional expression of chimeric receptor genes in human T cells. J Immunol Methods 248:67-76 (Pubitemid 32167025)
48. Romero P, Zippelius A, Kurth I, Pittet MJ, Touvrey C, Iancu EM, Corthesy P, Devevre E, Speiser DE, Rufer N (2007) Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol 178:4112-4119 (Pubitemid 46492360)